Raia Drogasil S.A. (RADLY)
OTCMKTS · Delayed Price · Currency is USD
3.245
+0.442 (15.79%)
Aug 6, 2025, 3:59 PM EDT
Raia Drogasil Market Cap
Raia Drogasil has a market cap or net worth of $4.66 billion as of August 6, 2025. Its market cap has decreased by -41.24% in one year.
Market Cap
4.66B
Enterprise Value
6.08B
Revenue
7.52B
Ranking
n/a
PE Ratio
20.77
Stock Price
$3.24
Market Cap Chart
Since November 26, 2008, Raia Drogasil's market cap has increased from 261.61M to 4.66B, an increase of 1,682.40%. That is a compound annual growth rate of 18.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 5, 2025 | 4.66B | -22.97% |
| Dec 30, 2024 | 6.05B | -41.88% |
| Dec 28, 2023 | 10.42B | 39.73% |
| Dec 29, 2022 | 7.45B | 3.88% |
| Dec 30, 2021 | 7.18B | -10.18% |
| Dec 30, 2020 | 7.99B | -12.78% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.93M |
| Veradigm | 806.69M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 532.81M |
| Glass House Brands | 467.07M |
| Northwest Biotherapeutics | 366.60M |
| CytoDyn | 347.26M |
| American Oncology Network | 330.70M |